News

Stocks of Olema Pharmaceuticals and Others Decline Pre-Market

Stocks of Olema Pharmaceuticals and Others Decline Pre-Market

Market Trends and Stock Movements

On a promising note, U.S. stock futures showed resilience this morning, seeing an uptick with the Dow futures recording an increase of approximately 0.2% at the outset of trading.

Olema Pharmaceuticals Inc’s Market Performance

However, shares of Olema Pharmaceuticals Inc (NASDAQ: OLMA) experienced a severe downturn, plummeting by 18.3% to $7.64 in early pre-market trading. This significant drop followed the company’s disclosure of new findings from its Phase 1b/2 trial examining the efficacy of palazestrant in combination with ribociclib for treating ER+/HER2- metastatic breast cancer, as presented at a recent medical conference.

Other Notable Stock Movements

In addition to Olema Pharmaceuticals, several other stocks are facing declines in their pre-market sessions. Here’s a closer look at these stocks:

  • Concord Medical Services Holdings Ltd (NYSE: CCM) saw a staggering decrease of 24.4%, trading down to $4.15 after a troubling 6% dip on the prior Friday.
  • Addex Therapeutics Ltd – ADR (NASDAQ: ADXN) faced a decline of 15.6%, with shares priced at $9.23, following a previous day’s gain of 28%.
  • Exelixis Inc (NASDAQ: EXEL) also witnessed declines, slipping 8.3% to $36.00 post-announcement of their Phase 3 STELLAR-303 pivotal trial results, which evaluated zanzalintinib in conjunction with an immune checkpoint inhibitor in metastatic colorectal cancer.
  • Cellectis SA (NASDAQ: CLLS) dropped 7.3%, priced at $3.69 in the pre-market trading.
  • Alumis Inc (NASDAQ: ALMS) had a slight decline of 6.7%, with shares trading at $4.19.
  • Nanobiotix SA – ADR (NASDAQ: NBTX) fell 6.3% to $23.98 after a 4% decrease the previous Friday.
  • Genmab A/S – ADR (NASDAQ: GMAB) decreased by 4.1%, trading at $31.81, despite reporting promising results for its therapy Rinatabart Sesutecan in advanced endometrial cancer.
  • Taysha Gene Therapies Inc (NASDAQ: TSHA) experienced a decline of 4%, settling at $4.53.

Market Outlook

As we move forward in this trading session, it is crucial to closely monitor these companies as they navigate through market fluctuations. The data being released and the investor reactions to these trends will ultimately shape their performance in the upcoming days.

Frequently Asked Questions

What caused the drop in Olema Pharmaceuticals' stock price?

The drop occurred due to the announcement of Phase 1b/2 trial data regarding their treatment for metastatic breast cancer, which influenced investor confidence negatively.

How did other biotech stocks perform in pre-market trading?

Several biotech stocks, including Exelixis and Addex Therapeutics, also experienced declines, reflecting a broader trend in the market.

Are there any stocks that gained in this trading session?

While the article focuses on declining stocks, it's essential to look at market trends for potential gainers separately.

Why are investors concerned about pre-market trading?

Pre-market trading can be indicative of how stocks will perform during the main trading session, often influenced by overnight news and events.

What is the importance of the Phase 3 STELLAR-303 trial for Exelixis?

The trial results could significantly impact Exelixis's stock value and investor confidence, determining the future direction of their treatment in the market.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Muyuan Foods Spotlights Smart Farming at EuroTier 2026

Updated Category News Views 210

Muyuan Foods Ready to Impress at EuroTier 2026 Let's face it, folks—when you think of game-changers in pig farming, Muyuan Foods Group deserves a nod. They're not just trotting out oinkers left and right; they're steering the whole paddock with innovations in smart pig farming and green development solutions. At EuroTier 2026 in Hanover, Muyuan’s booth—J04 in Hall...

Continue Reading
Off-Broadway Play 'DUST' Raises Autism Support Funds

Updated Category News Views 238

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Continue Reading
Pigeon Unveils Green Innovations at CIIE 2026

Updated Category News Views 204

An International Celebration: Cultural Connections at CIIE Babies have a way of bringing the world together. Every culture has its own quirks and traditions, but the love for a newborn is common ground. Pigeon gets that, and they're putting it on full display at the China International Import Expo (CIIE) in Shanghai. It's their fourth run at this rodeo, and they’re not...

Continue Reading
Paris Baguette Pioneers Drive-Thru in Oklahoma

Updated Category News Views 327

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 188

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 166

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Cultural Bridges and Mazu's Spirit: Gen Z's Role

Updated Category News Views 183

Youthful Energy Revives Ancient Traditions Over in Putian, China, you'd have seen a curious sight in late October—hundreds of young folks from over 20 corners of the globe gathering not for a concert or some influencer meet-up, but to dive into Mazu's legacy. This ain't your typical cultural event. More than 200 Gen Z representatives came together, bridging their...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 140

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 138

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 227

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading

Top 5 Most Recently Viewed Articles

Syntec Optics Reaches Major Achievement in Space Optics Production

Updated Category News Views 154

Syntec Optics Celebrates Production Milestone Syntec Optics Holdings, Inc. (NASDAQ: OPTX) has recently achieved a monumental milestone in its production line by manufacturing its 17,000th satellite optic. This accomplishment marks a significant step for the company, which stands as a leader in developing technology products across various sectors, including defense,...

Continue Reading
Exploring the Growth of the Global Burn Care Industry

Updated Category News Views 212

The Expansion of the Burn Care Market The global Burn Care Market has witnessed remarkable growth, valued at approximately US$2.46 billion in recent evaluations. Forecasts indicate this figure is set to increase significantly, reaching an impressive US$3.35 billion by the end of the decade. This growth is primarily influenced by various factors contributing to the rising...

Continue Reading
DCS Corporation Triumphs with OASIS+ Contract Award

Updated Category News Views 154

DCS Corporation Triumphs with OASIS+ Contract Award DCS Corporation has recently celebrated a pivotal achievement by securing an unrestricted prime contract under the General Services Administration's One Acquisition Solution for Integrated Services Plus (OASIS+). This noteworthy award spans all four key service domains: Management & Advisory, Technical & Engineering,...

Continue Reading
Meta's AI-Powered Glasses Surge in Popularity and Demand

Updated Category News Views 159

Overview of Meta's AI Glasses Innovation Meta Platforms has recently made headlines with the launch of its cutting-edge artificial intelligence (AI) glasses, known as the Meta Ray-Ban Display. These smart glasses combine stylish design with advanced technology, featuring a built-in display and a neural wristband that allows users to control the device through intuitive...

Continue Reading
Smartmatic's $2.7 Billion Lawsuit Against Fox News Moves Forward

Updated Category News Views 266

Smartmatic's Legal Challenge Against Fox News In a significant ruling, a New York state appeals court has decided that Fox News must confront a $2.7 billion defamation lawsuit brought forth by Smartmatic, a voting machine company. This lawsuit stems from allegations made on air related to the contentious 2020 U.S. presidential election, leading to serious legal...

Continue Reading